Nα-(Fmoc-aminoethyl)-D-Arg(Pbf)-OMe
Nα-(Fmoc-aminoethyl)-D-Arg(Pbf)-OMe - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.ON-1007
-
SMILESN=C(NS(C1=C(C)C(CC(C)(C)O2)=C2C(C)=C1C)(=O)=O)NCCC[C@@H](NCCNC(OCC3C(C=CC=C4)=C4C5=C3C=CC=C5)=O)C(OC)=O.Cl
-
Molecular Weight705.87 (free base)
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityHPLC≥98%
-
Storage Condition-20±5℃
Documentation
Documentation
-
Catalog No.ON-1007
-
SMILESN=C(NS(C1=C(C)C(CC(C)(C)O2)=C2C(C)=C1C)(=O)=O)NCCC[C@@H](NCCNC(OCC3C(C=CC=C4)=C4C5=C3C=CC=C5)=O)C(OC)=O.Cl
-
Molecular Weight705.87 (free base)
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityHPLC≥98%
-
Storage Condition-20±5℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
